Sustained Release of Actives With Montanide™ ISA 51 VG and Montanide™ ISA 720 VG, Two Adjuvants Dedicated to Human Therapeutic Vaccines

Journal for ImmunoTherapy of Cancer - United Kingdom
doi 10.1186/2051-1426-3-s2-p429
Full Text
Abstract

Available in full text

Date
Authors
Publisher

BMJ

Related search

Comparative Evaluation of Different Inactivated Rift Valley Fever Virus Vaccine Adjuvanted With Montanide Oil ISA 61 VG, Montanide Oil ISA 201 VG, and Aluminum Hydroxide Gel

Benha Veterinary Medical Journal
2015English

Safety and Immunogenicity of Multi-Antigen AMA1-based Vaccines Formulated With CoVaccine HT™ and Montanide ISA 51 in Rhesus Macaques

Malaria Journal
ParasitologyInfectious Diseases
2011English

Evaluation of Inactivated Rift Valley Fever Virus Vaccine Adjuvanted With Montanide Oil ISA 201 VG

Benha Veterinary Medical Journal
2015English

The Comparison of the Efficacy of Swine FMD Vaccine Emulsified With Oil Adjuvant of ISA 201 VG or ISA 206 VG

Journal of Biosciences and Medicines
2013English

Induction of Protective Cytotoxic T Cells to Murine Cytomegalovirus by Using a Nonapeptide and a Human-Compatible Adjuvant (Montanide ISA 720).

Journal of Virology
Insect ScienceImmunologyMicrobiologyVirology
1995English

Phase 1 Immunotherapy Trial With Two Chimeric HER-2 B-Cell Peptide Vaccines Emulsified in Montanide ISA 720VG and Nor-MDP Adjuvant in Advanced Solid Tumors

Clinical Cancer Research
Cancer ResearchOncology
2019English

دراسة تحلیلیة مقارنة بین معیار المراجعة الدولى Isa 720 المعدل لسنة 2015، ونظیره المصرى الحالى رقم 720

مجلة الاسکندریة للبحوث المحاسبیة
2017English

International Seabed Authority (ISA)

2009English

VrR-VG: Refocusing Visually-Relevant Relationships

2019English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy